Profile
Corporate information
Official name
Mitra Biotech Pvt Ltd
Registration country
Investment activity status
Active investor
Company type
Developer of personalized cancer treatments.Funding
Funding rounds
Series B USD 27,400,000
USD 27,400,000 (29 Aug 2016)
Funding to expand the availability of its CANScript service, which predicts personalised responses to cancer treatments. Part of the proceeds were used to cash out Series A backers Karnataka Information Technology Venture Capital Fund and India Innovation
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Sands Capital Ventures LLC | United States | Led the round. | |
|
Sequoia Capital India and South East Asia | India | Led the round. | |
|
RA Capital Management | Initial investment. Round participant. | ||
|
Accel Partners & Co Inc | Early and growth stage venture capital firm. | United States | Follow-on investment. Round participant. |
|
Tata Capital Innovations Fund | India | Follow-on investment. Round participant. |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Accel Partners & Co Inc | Early and growth stage venture capital firm. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Accel Partners & Co Inc Early and growth stage venture capital firm. |
+1 (415) 293-1100 |
N/A Series B |
|
|
RA Capital Management |
Series B | |
|
|
Sands Capital Ventures LLC |
Series B | |
|
|
Sequoia Capital India and South East Asia |
+91 (11) 4956-7200 |
Series B |
|
|
Tata Capital Innovations Fund |
Series B |